+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Bariatric Surgery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon

    Report

  • 125 Pages
  • June 2022
  • Region: United States
  • Mordor Intelligence
  • ID: 5119838
The United States bariatric surgery market was valued at USD 668.78 million in 2021 and is expected to project growth at a CAGR of 8.1% during the forecast period. There are certain factors propelling the growth of the market, including increasing obesity patients, growing government initiatives to curb obesity, and a rising prevalence rate of type 2 diabetes and heart diseases in the country.

As per United States National Health Statistics Reports published in June 2021, among adults aged 20 and over, the prevalence of obesity was 41.9%, severe obesity was 9.2%, and diabetes was 14.8%. The increase in the prevalence of obesity among the population is expected to drive the bariatric surgery market in the United States. Furthermore, the presence of established healthcare infrastructure along with the presence of a large number of market players in the country is expected to boost market growth over the forecast period. For instance, in September 2020, Ethicon, part of Johnson & Johnson Medical Devices Companies, launched ECHELON ENDOPATH Staple Line Reinforcement (SLR), a buttressing device designed to reduce potential complications during bariatric procedures.

Key Market Trends


Closure Device Segment is Expected to Register a High CAGR in the Assisting Device Segment


Closure devices are used to reconnect tissues during surgical procedures, also for closing incisions made by trocars. The laparoscopic port closure device helps obese patients undergoing bariatric procedures and surgeries by successfully and safely closing port sites.

The closure devices segment is expected to show high growth, as they are widely used in minimally invasive surgeries, where immediate closure of very small incisions made at the time of surgical procedures is required.

In May 2021, Standard Bariatrics announced the launch of its novel Titan SGS stapling technology, specifically designed for bariatric sleeve surgery, also the device has been cleared by the United States Food and Drug Administration (FDA). These new product launches by major players for new closure devices are propelling the studied market growth.

In 2019, in the United States, the adult obesity rates exceeded 35% in nine states, 30% in 31 states, and 25% in 48 reports the Behavioral Risk Factor Surveillance System (BRFSS) 2019 data. According to the same source, Mississippi and West Virginia carried the highest adult obesity rate at 39.5% and Colorado had the lowest rate at 23%. Also, the reports summed up by Trust for America's Health organization, in 2020 the adult obesity rate was at 42.4%, the first time the national rate has passed the 40% mark and national adult obesity rate has increased by 26% since 2008. These increasing burden of obesity among population is increasing the demand of bariatric surgeries and these increases the demand for more closure devices to be used for bariatric surgeries and contribute to the faster growth of this segment.






Competitive Landscape


The United States bariatric surgery market is moderately consolidated competitive with the presence of major players, such as Medtronic PLC, Johnson and Johnson (Ethicon Inc.), Apollo Endo-surgery Inc., Aspire Bariatrics Inc Intuitive Surgical Inc., B. Braun Melsungen AG, Olympus Corporation, The Cooper Companies, Conmed Corporation among others. The market is also inclusive of the smaller players that hold a substantial market share. With the growing medical device market, it is expected that a few more new players will be penetrating the market in the coming future.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Obesity Patients
4.2.2 Rising Prevalence Rate of Type 2 Diabetes and Heart Diseases
4.2.3 Growing Government Initiatives to Curb Obesity
4.3 Market Restraints
4.3.1 High Cost of Surgery
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Device
5.1.1 Assisting Devices
5.1.1.1 Suturing Device
5.1.1.2 Closure Device
5.1.1.3 Stapling Device
5.1.1.4 Trocars
5.1.1.5 Other Assisting Devices
5.1.2 Implantable Devices
5.1.2.1 Gastric Bands
5.1.2.2 Electrical Stimulation Devices
5.1.2.3 Gastric Balloons
5.1.2.4 Gastric Emptying
5.1.2.5 Other Devices
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Johnson and Johnson (Ethicon Inc)
6.1.3 Apollo Endosurgery Inc.
6.1.4 Aspire Bariatrics Inc.
6.1.5 Intuitive Surgical Inc.
6.1.6 B. Braun Melsungen AG
6.1.7 Olympus Corporation
6.1.8 The Cooper Companies
6.1.9 Conmed Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Medtronic PLC
  • Johnson and Johnson (Ethicon Inc)
  • Apollo Endosurgery Inc.
  • Aspire Bariatrics Inc.
  • Intuitive Surgical Inc.
  • B. Braun Melsungen AG
  • Olympus Corporation
  • The Cooper Companies
  • Conmed Corporation

Methodology

Loading
LOADING...